Docosahexaenoic and eicosapentaenoic acids inhibit human lymphoproliferative responses in vitro but not the expression of T cell surface activation markers

Scandinavian Journal of Immunology

Volumn 43, Issue 3, 1996, Pages 248-256

  Khalfoun, B ^a   Thibault, G ^a   Lacord, M ^a   Gruel, Y ^a   Bardos, P ^a   Lebranchu, Y ^a  

^a UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; CD71 ANTIGEN; DOCOSAHEXAENOIC ACID; HLA DR ANTIGEN; ICOSAPENTAENOIC ACID; INTERLEUKIN 2 RECEPTOR; POLYUNSATURATED FATTY ACID;

ADULT; ARTICLE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029872394     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-42.x     Document Type: Article

References (30)

1. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development Am J Clin Nutr 1991;54:438-6.
2. Adams DH, Wyner LR, Steinbeck MJ, Karovsky MJ. Inhibition of graft atheriosclerosis by modulation of the inflammatory response. Transplant Proc 1993;25:2092-8.
3. Kremer JM, Lawrence DA, Jubiz W et al. Dietary fish oil and olive oil supplementation in patients with rhumatoid arthritis. Arthritis Rheum 1990;33:810-18.
4. Flower KH, Chapin RS, Murray DN. Effects of purified dietary n-3 ethyl esters on murine T lymphocyte function. J Immunol 1993;151:5186-97.
5. Endres S, Meydani SN, Ghorbani R, Shindler R, Dinarello CA. Dietary supplementation with n-3 fatty acids suppress interleukin-2 production and mononuclear cell proliferation. J Leukoc Biol 1993;54:599-603.
6. Aki H, Morinaga SI, Yamazaki K, Suzuki H, Nakamura N. Reduction of delayed-type hypersensitivity by the injection of n-3 polyunsaturated fatty acids in mice. Transplantation 1992; 54:511-14.
7. Calder PC, Bevan SJ, Newsholme EA. The inhibition of T-lymphocyte proliferation by fatty acid is via an eicosanoid-independent mechanism. Immunol 1992;75:108-15.
8. Soyland E, Nenseter MS, Braten L, Drevon CA. Very long chain n-3 and n-6 polyunsaturated fatty acids inhibit proliferation of human T-lymphocytes in vitro. Eur J Clin Invest 1993;23:112-21.
9. Brouad C, Pascaud M. Modulation of rat and human lymphocyte function by n-3 and n-6 polyunsaturated fatty acids and acetylsalicylic acid. Ann Nutr Metab 1993;37:146-59.
10. Calder PC, Newsholme EA. Polyunsaturated fatty acids suppress human peripheral blood lymphocyte proliferation and interleukin-2 production. Clin Science 1992;37:695-700.
11. Devon CA. Marine oils and their effects. Nutr Rev 1992;50: 38-42.
12. Guichardant M, Fraither H, Spielmann M, Sprecher H, Finot PA. Steradonic acid, an inhibtor of the 5 lipoxygenase pathway. A comparison with timnodonic and dihomogammalinolenic acids. Lipids 1993;28:321-4.
13. Khalfoun B, Valentin JF, Sizaret PY et al. In vitro inhibitory effect of docosahexaenoic and eicosapentaenoic acids on human endothelial cell production of interleukin-6. Endothelium 1994; 2:183-90.
14. Bôyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968;21:197-202.
15. Khalfoun B, Degenne D, Crouzat Reynes G, Bardos P. Effects of human syncytiotrophoblast plasma membrane soluble extracts on in vitro mitogen-induced lymphocyte proliferation. A possible inhibition mechanism involving the transferrin receptor. J Immunol 1986;137:1187-93.
16. Mikkelsen L, Hansen H, Grunnet N, Dich J. Cytoprotective effect of tocopherols in hepatocytes cultured with polyunsaturated fatty acids. Lipids 1994,29:369-72.
17. Meydani M, Vitamin E. Lancet 1995;345:170-6.
18. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994;76:241-53.
19. Harris W, Connor W, McMurry M. The comparative reductions of the plasma lipis and lipoproteins by dietary polyunsaturated fats; salmon oil versus vegetable oil. Metabolism 1983;32:179-84.
20. Bonaa K, Bjerve K, Straume B, Gram I, Thelle D. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. N Engl J Med 1990;322:795-801.
21. Calder PC. Fatty acids, dietary lipids and lymphocyte functions. Biochem Soc Trans 1994;23:302-9.
22. Sillwell W, Ehringer W, Jenski LJ. Docosahexaenoic acid increases permeability of lipid vesicles and tumor cells. Lipids 1993;28:103-8.
23. Weiss A, Imboden J, Hardy K, Manger B, Terhorst C, Stobo J. The role of the T3/antigen receptor complex in T cell activation. Ann Rev Immunol 1986;4:593-619.
24. Cheung RK, Grinstein S, Gelfand EW. Permissive role of calcium in the inhibition of T-cell mitogenesis by calmodulin antagonistic. J Immunol 1983;131:2291-8.
25. Goldyne ME, Stobo JD. Immunoregulatory properties of prostaglandins and related lipids. Crit Rev Immunol 1981;2:189-98.
26. Shapiro AC, Wu D, Meydani SN. Eicosanoids derived from arachidonic and eicosapentaenoic acids inhibit T cell proliferation. Prostaglandins 1993;45:229-40.
27. Santoli D, Zurier RB. Prostaglandin E precursor fatty acids inhibit human IL-2 production by a prostaglandin E-dependent mechanism. J Immunol 1989;143:1300-9.
28. Grabstein KH, Eisenman J, Shanbeck K et al. Cloning of a T cell growth factor that interacts with the B chain of the interleukin-2 receptor. Science 1994;264:965-8.
29. Thomson AW, Starlz TE. New immunosuppressive drugs: mechanistic insights and potential therapeutic advances. Immunological Rev 1993;136:72-98.
30. Chouaib S, Welte K, Mertelsmann R, Dupont B. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of IL-2 production and downregulation of transferrin receptor expression. J Immunol 1985;135:1172-79.